Eva Castro-De - Publications

Safety and real-world outcomes from a home-based, systemic anticancer therapy program: A prospective observational study.

Journal: International journal of nursing studies

Published: April 24, 2026

Real-world management and outcome of patients with pancreatic adenocarcinoma. Results of the Spanish RETUD gastrointestinal registry.

Journal: ESMO real world data and digital oncology

Published: February 06, 2026

Real-world characterization of PD-L1 expression in patients with advanced esophagogastric adenocarcinoma in Spain.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: December 19, 2025

Venous thrombosis in lung cancer compared with other tumors: results from the TESEO-SEOM registry.

Journal: Thrombosis research

Published: September 01, 2025

Does perioperative FLOT increase cure rates in resectable esophageal adenocarcinoma? A mixture cure model analysis.

Journal: British journal of cancer

Published: June 25, 2025

Gene-Specific Detection Rate of Adenomas and Advanced Adenomas in Lynch Syndrome.

Journal: Gastroenterology

Published: September 22, 2024

Safety and efficacy of encorafenib-cetuximab combination in BRAF V600E -mutated metastatic colorectal cancer: real-world evidence from the CONFIDENCE Spanish multicenter study.

Journal: ESMO real world data and digital oncology

Published: July 16, 2024

Characterization of thrombosis risk in ambulatory patients with cancer: results of the observational, prospective, multicenter CARTAGO study.

Journal: The oncologist

Published: June 13, 2024

Is there a preferred platinum and fluoropyrimidine regimen for advanced HER2-negative esophagogastric adenocarcinoma? Insights from 1293 patients in AGAMENON-SEOM registry.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: December 22, 2023

Three-year survival follow-up of patients with gastrointestinal cancer treated during the COVID-19 pandemic in Spain: data from the PANDORA-TTD20 study.

Journal: The oncologist

Published: October 08, 2023

Validation of the CoVID-TE model as a tool to predict thrombosis, bleeding, and mortality in the oncology patient with Sars-Cov-2 infection: a study by the SEOM cancer and thrombosis group.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: March 01, 2023

Immune checkpoint inhibitor-associated thrombosis in patients with bladder and kidney cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: February 14, 2023